We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The Medicines and Healthcare products Regulatory Agency (MHRA) and Health Inspectorate Wales (HIW) set out key principles to support their collaboration on improving public health.…
The Prime Minister will visit China for three days from today in a trip intended to build on the existing strong ties between our two countries.
The Medicines and Healthcare products Regulatory Agency (MHRA) is working in partnership with Slimming World as part of the Agency’s wider #FakeMeds Campaign to encourage those wanting to lose weight to turn to safe, legitimate and appropriate routes.…
Following consultation and advice from the Commission on Human Medicines, MHRA is reclassifying Viagra Connect from POM to P.
In response to stakeholders, Public Health England (PHE) and NHS England have published an update on the PrEP Impact trial.
The Medicines Healthcare products Regulatory Agency (MHRA) has launched a social media campaign to promote reporting of suspected side effects from over-the-counter medicines.
Dr Jeremy Farrar OBE, Director of the Wellcome Trust delivered the 12th Annual Lecture organised by the Medicines and Healthcare products Regulatory Agency in London tonight
The Medicines and Healthcare products Regulatory Agency (MHRA) and Care Quality Commission (CQC) set out key principles to support their collaboration on improving public health.
Advice for women following the decision by Bayer to withdraw the Essure device from the European Market.
Following their joint conference, BIA and MHRA publish report ‘Innovation in life sciences in a changing and dynamic environment’
The Medicines and Healthcare products Regulatory Agency is conducting a survey to better understand how it can support its customers
A Southall man has been jailed for the illegal supply and sale of unlicensed medicines.
The interactive guide will help new and experienced manufacturers navigate their obligations under new EU regulations on medical devices.
MHRA are investigating a number of Hightop HIV/AIDS Home Test Kits that may be unreliable and may provide false results.
Reclassification of Dovonex Psoriasis Ointment approved by MHRA
Medicines and Healthcare products Regulatory Agency (MHRA) have today announced the approval of Dovonex Psoriasis 50microgram/g Ointment, which will be available through pharmacies without prescription.
Professor Sir Michael will return as Chair for a second term.
MHRA reclassifies Nasonex Allergy Control
MHRA reclassifies Otrivine Extra Dual Relief Nasal Spray Solution
Maloff Protect anti-malarial tablets will shortly be available to buy from pharmacies, after previously only being available to purchase with a prescription.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).